Clinical Trial Update: A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of somapacitan for pediatric growth disorders; results have been posted for conditions including small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature
• Noonan Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Somapacitan (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: SGA, Turner Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-11-21